In 2024, 40% fewer people acquired HIV and 54% fewer died from AIDS-related causes than in 2010. Many countries around the world have invested extensively in combating the HIV/AIDS epidemic, with one country making notable progress despite the many obstacles it faces: Guyana.

Guyana is a country in the northeast region of South America, with a population of 878,674 as of 2022, largely centered on and around the Caribbean coastline. It was until the recent discovery of offshore oil reserves one of the poorest countries in South America, a socioeconomic effect which still impacts the country today in regard to government resources and public health.

Medical hospital infrastructure for instance was, until the most recent decade, a costly and difficult expense. Accessing necessary health treatment required a challenging trip to the capital city, Georgetown, often taking more than half a day to complete and having a disproportionate impact on low-income patients in terms of health and accessibility. Here is more information about HIV/AIDS in Guyana and what some are doing to address it.

International and Governmental Efforts

Recent strategic investments by the Government of Guyana, the Pan-American Health Organization (PAHO) and the World Health Organization (WHO) have helped expand the region’s health care network. These ongoing efforts from international support organizations will, by 2027, open five more “smart” hospitals in the country which will provide far more expansive and high-quality healthcare access than ever before.

Similarly, the Universal Health Voucher Programme (UHVP) was a 2025 initiative by the Government of Guyana through the Ministry of Health, aimed at improving healthcare service accessibility to all of Guyana’s citizens by providing each member of the public a $10,000 health voucher and reduced costs for valuable medical tests. The current president of Guyana, President Mohamed Irfaan Ali, launched the UHVP with the goal of improving Guyanese healthcare and especially through improved health monitoring and early addressing of health conditions.

Critically Affected Populations

Research shows that HIV is still among the leading public health challenges in Guyana and the Caribbean, largely due to the combination of HIV/AIDS solutions lacking full accessibility and awareness in everyday life in Guyana.

There are an estimated 11,000 HIV/AIDS cases in Guyana, a prevalence of 1.5% among the population, and new cases have risen by 19% since 2010. This is compared to the global average of HIV/AIDS, which among adults aged 15–49 sits at around 0.7%, or less than half of Guyana’s HIV impact.

In 2017, the Global Fund approved an HIV grant of $4,539,985 to the Guyana Ministry of Health, lasting from the beginning of 2018 to the end of 2020. The proposed grant program targeted an epidemic of diverse and vulnerable populations, those being “men who have sex with men (MSM), female sex workers, transgender people, miners and loggers,” according to the Global Fund Technical Review Panel (TRP). The program worked to assess and implement a coordinated variety of strategies to address these populations and treat any and all HIV/AIDS cases more broadly, building upon recent efforts by Guyana on aiding key populations and with the goal of eliminating HIV/AIDS and addressing detrimental social and economic impacts the epidemic creates.

Eliminating HIV/AIDS in Guyana

Guyana has made significant progress in its efforts to eliminate HIV/AIDS, though has not managed to meet its optimistic 95-95-95 targets completely. These goals mean for 95% of persons living with HIV to know their disease status, for 95% of persons with HIV/AIDS to have active treatment, and for 95% on treatment to have viral suppression aid. As of the National AIDS Programme 2023 Annual Report, Guyana has reported 94%, 72%,and 87% respectively, showing substantial improvement from a decade prior but without the 95% benchmarks being met which would signal an effective and complete eradication of the epidemic.

However, HIV infections are certainly not yet a settled case in the country. The year 2024 saw almost 500 new HIV infections recorded, with many of them being preventable, according to Guyana’s Health Minister Dr. Frank Anthony. Guyana provides free nationwide testing and treatment services for HIV/AIDS, which is why this increase is so hard to explain by conventional resource explanations.

Studies assessing young people’s knowledge of HIV/AIDS and their views on sexual behavior and contraceptives in Guyana may help explain why. Almost a quarter of teenagers ages 12-14 years old were sexually active, jumping to more than one-third of teenagers for ages 15 or older. Just two out of every five of these groups utilized condoms and other measures, reflecting attitudes toward HIV/AIDS prevention affected by a lack of public knowledge and importance due to age and educational and religious teaching on these contraceptives. Guyanese cases ages 15-24 accounted for 14% of the 580 new HIV/AIDS infections recorded in 2023, and HIV prevalence for the age group rose from 0.2% to 0.3%, suggesting the problem is increasing despite measures being taken.

Actions by the Guyanese Ministry of Health

Rates of HIV/AIDS have stayed constant throughout the country as well, suggesting that the increased health accessibility reforms by Guyana’s government have not had the intended effect in the country. The Government of Guyana already funds every test, HIV tablet, ARV and viral load test, in contrast to most other developing countries which tend to rely on international financing for HIV/AIDS healthcare support.

The Government of Guyana additionally introduced PrEP (pre-exposure prophylaxis) pills in 2019 through the Ministry of Health and the National AIDS Programme Secretariat (NAPS), pills which are highly effective in treatment for HIV/AIDS, but which have been largely ineffective due to a lack of public awareness. Research shows that PrEP awareness in Guyana exists largely through media sources, whereas PrEP access is significantly less commonly prescribed by a health care provider. 

Many are concerned about limited access, side effects, and inadequate provider engagement in PrEP and other HIV/AIDS treatments, illustrating a lack of success in providing sufficient awareness efforts by the Guyanese government. However, more than half of the research participants also expressed a willingness to use PrEP, and more than three-quarters expressed a willingness to recommend it to their peers.

Final Thoughts

HIV/AIDS efforts in Guyana have been moderately successful, particularly in expanding healthcare access and treatment potential. Continued problems exist with spreading accurate information and reducing the systemic barriers present to current health care inaccessibility in Guyana, yet greater provider training, routine PrEP integration into medical spaces and targeted community outreach to improve public perception and access can combat it.

– Matthew Hecomovich

Matthew is based in Davis, CA, USA and focuses on Global Health for The Borgen Project.

Photo: Wikimedia Commons